Does the media refer more to LIVN or KMTS?

In the previous week, Kestra Medical Technologies had 2 more articles in the media than LivaNova. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for LivaNova. LivaNova's average media sentiment score of 0.89 beat Kestra Medical Technologies' score of 0.62 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, KMTS or MMED?

MiniMed Group has higher revenue and earnings than Kestra Medical Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kestra Medical Technologies $59.81M 22.04 -$113.81M -$3.96 N/A MiniMed Group $2.99B 1.34 N/A N/A N/A

Does the media refer more to KMTS or MMED?

In the previous week, Kestra Medical Technologies had 2 more articles in the media than MiniMed Group. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for MiniMed Group. Kestra Medical Technologies' average media sentiment score of 0.62 beat MiniMed Group's score of 0.50 indicating that Kestra Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to KMTS or WRBY?

In the previous week, Warby Parker had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 7 mentions for Warby Parker and 4 mentions for Kestra Medical Technologies. Warby Parker's average media sentiment score of 0.79 beat Kestra Medical Technologies' score of 0.62 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Warby Parker 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Kestra Medical Technologies (KMTS) Competitors

$22.58 +0.50 (+2.26%)

Closing price 04:00 PM Eastern

Extended Trading

$22.62 +0.04 (+0.18%)

As of 04:10 PM Eastern

Compare

KMTS vs. LIVN, NVST, MMED, IRTC, and WRBY

Should you buy Kestra Medical Technologies stock or one of its competitors? MarketBeat compares Kestra Medical Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kestra Medical Technologies include LivaNova (LIVN), Envista (NVST), MiniMed Group (MMED), iRhythm Technologies (IRTC), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

How does Kestra Medical Technologies compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

LivaNova has a net margin of 7.48% compared to Kestra Medical Technologies' net margin of -171.87%. LivaNova's return on equity of 16.48% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%

Kestra Medical Technologies has lower revenue, but higher earnings than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.21	-$242.47M	$1.95	41.56
Kestra Medical Technologies	$59.81M	22.04	-$113.81M	-$3.96	N/A

LivaNova has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

In the previous week, Kestra Medical Technologies had 2 more articles in the media than LivaNova. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for LivaNova. LivaNova's average media sentiment score of 0.89 beat Kestra Medical Technologies' score of 0.62 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova presently has a consensus price target of $80.75, indicating a potential downside of 0.37%. Kestra Medical Technologies has a consensus price target of $27.40, indicating a potential upside of 21.35%. Given Kestra Medical Technologies' higher probable upside, analysts plainly believe Kestra Medical Technologies is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

97.6% of LivaNova shares are owned by institutional investors. 0.4% of LivaNova shares are owned by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

LivaNova beats Kestra Medical Technologies on 11 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Envista?

Envista (NYSE:NVST) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Envista has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Envista has a net margin of 2.41% compared to Kestra Medical Technologies' net margin of -171.87%. Envista's return on equity of 7.11% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%

Envista has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.59	$47M	$0.41	64.86
Kestra Medical Technologies	$59.81M	22.04	-$113.81M	-$3.96	N/A

In the previous week, Kestra Medical Technologies had 4 more articles in the media than Envista. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 0 mentions for Envista. Envista's average media sentiment score of 0.89 beat Kestra Medical Technologies' score of 0.62 indicating that Envista is being referred to more favorably in the media.

Company	Overall Sentiment
Envista	Positive
Kestra Medical Technologies	Positive

Envista currently has a consensus target price of $28.67, indicating a potential upside of 7.80%. Kestra Medical Technologies has a consensus target price of $27.40, indicating a potential upside of 21.35%. Given Kestra Medical Technologies' higher probable upside, analysts clearly believe Kestra Medical Technologies is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Envista beats Kestra Medical Technologies on 10 of the 13 factors compared between the two stocks.

How does Kestra Medical Technologies compare to MiniMed Group?

Kestra Medical Technologies (NASDAQ:KMTS) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Kestra Medical Technologies presently has a consensus price target of $27.40, suggesting a potential upside of 21.35%. MiniMed Group has a consensus price target of $21.33, suggesting a potential upside of 50.02%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

MiniMed Group has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -171.87%. MiniMed Group's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
MiniMed Group	N/A	N/A	N/A

19.7% of MiniMed Group shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 2.2% of MiniMed Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

MiniMed Group has higher revenue and earnings than Kestra Medical Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	22.04	-$113.81M	-$3.96	N/A
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A

In the previous week, Kestra Medical Technologies had 2 more articles in the media than MiniMed Group. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 2 mentions for MiniMed Group. Kestra Medical Technologies' average media sentiment score of 0.62 beat MiniMed Group's score of 0.50 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

MiniMed Group beats Kestra Medical Technologies on 8 of the 12 factors compared between the two stocks.

How does Kestra Medical Technologies compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

iRhythm Technologies has a net margin of -3.53% compared to Kestra Medical Technologies' net margin of -171.87%. iRhythm Technologies' return on equity of -10.26% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%

iRhythm Technologies has higher revenue and earnings than Kestra Medical Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.10	-$44.55M	-$0.86	N/A
Kestra Medical Technologies	$59.81M	22.04	-$113.81M	-$3.96	N/A

In the previous week, Kestra Medical Technologies had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 4 mentions for Kestra Medical Technologies and 3 mentions for iRhythm Technologies. Kestra Medical Technologies' average media sentiment score of 0.62 beat iRhythm Technologies' score of 0.00 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kestra Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies currently has a consensus target price of $187.38, indicating a potential upside of 61.55%. Kestra Medical Technologies has a consensus target price of $27.40, indicating a potential upside of 21.35%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe iRhythm Technologies is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

iRhythm Technologies beats Kestra Medical Technologies on 11 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Warby Parker?

Kestra Medical Technologies (NASDAQ:KMTS) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Kestra Medical Technologies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, meaning that its stock price is 96% more volatile than the broader market.

Kestra Medical Technologies currently has a consensus price target of $27.40, suggesting a potential upside of 21.35%. Warby Parker has a consensus price target of $29.50, suggesting a potential upside of 7.92%. Given Kestra Medical Technologies' higher probable upside, research analysts clearly believe Kestra Medical Technologies is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64

In the previous week, Warby Parker had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 7 mentions for Warby Parker and 4 mentions for Kestra Medical Technologies. Warby Parker's average media sentiment score of 0.79 beat Kestra Medical Technologies' score of 0.62 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Warby Parker	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Warby Parker has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$59.81M	22.04	-$113.81M	-$3.96	N/A
Warby Parker	$871.91M	3.36	$1.64M	$0.02	1,366.75

Warby Parker has a net margin of 0.15% compared to Kestra Medical Technologies' net margin of -171.87%. Warby Parker's return on equity of 2.30% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-171.87%	-65.49%	-46.39%
Warby Parker	0.15%	2.30%	1.18%

93.2% of Warby Parker shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 16.8% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Warby Parker beats Kestra Medical Technologies on 14 of the 16 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KMTS vs. The Competition

Export

Metric	Kestra Medical Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.29B	$8.41B	$6.62B	$12.27B
Dividend Yield	N/A	2.53%	2.67%	5.96%
P/E Ratio	-5.70	12.74	22.00	22.10
Price / Sales	22.04	7.09	543.35	100.30
Price / Cash	N/A	17.16	46.33	53.91
Price / Book	5.65	3.27	10.51	6.32
Net Income	-$113.81M	$226.25M	$3.57B	$337.22M
7 Day Performance	13.30%	-0.65%	0.81%	-1.20%
1 Month Performance	4.34%	-1.91%	0.68%	0.40%
1 Year Performance	27.71%	1.71%	30.98%	29.26%

Kestra Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KMTS Kestra Medical Technologies	2.2326 of 5 stars	$22.58 +2.3%	$27.40 +21.3%	+25.2%	$1.29B	$59.81M	N/A	300	News Coverage
LIVN LivaNova	1.7365 of 5 stars	$78.50 flat	$79.38 +1.1%	+73.7%	$4.31B	$1.43B	40.26	3,300	Analyst Forecast
NVST Envista	1.7999 of 5 stars	$25.94 +0.1%	$28.67 +10.5%	+37.4%	$4.22B	$2.72B	63.26	12,000
MMED MiniMed Group	3.7936 of 5 stars	$14.77 flat	$21.33 +44.4%	N/A	$4.15B	$2.99B	N/A	8,000	High Trading Volume
IRTC iRhythm Technologies	4.1956 of 5 stars	$104.65 flat	$187.38 +79.1%	-26.8%	$3.44B	$787.85M	N/A	2,400	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KMTS) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. LIVN, NVST, MMED, IRTC, and WRBY

How does Kestra Medical Technologies compare to LivaNova?

Summary

How does Kestra Medical Technologies compare to Envista?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Summary

How does Kestra Medical Technologies compare to Warby Parker?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. LIVN, NVST, MMED, IRTC, and WRBY

How does Kestra Medical Technologies compare to LivaNova?

Is LIVN or KMTS more profitable?

Which has stronger earnings and valuation, LIVN or KMTS?

Which has more volatility and risk, LIVN or KMTS?

Does the media refer more to LIVN or KMTS?

Do analysts rate LIVN or KMTS?

Do insiders and institutionals have more ownership in LIVN or KMTS?

Summary

How does Kestra Medical Technologies compare to Envista?

Which has more volatility & risk, NVST or KMTS?

Is NVST or KMTS more profitable?

Which has better earnings & valuation, NVST or KMTS?

Does the media refer more to NVST or KMTS?

Do analysts rate NVST or KMTS?

Summary

How does Kestra Medical Technologies compare to MiniMed Group?

Do analysts rate KMTS or MMED?

Is KMTS or MMED more profitable?

Do institutionals and insiders have more ownership in KMTS or MMED?

Which has higher valuation & earnings, KMTS or MMED?

Does the media refer more to KMTS or MMED?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Which has more volatility & risk, IRTC or KMTS?

Is IRTC or KMTS more profitable?

Which has higher earnings & valuation, IRTC or KMTS?

Does the media favor IRTC or KMTS?

Do analysts prefer IRTC or KMTS?

Summary

How does Kestra Medical Technologies compare to Warby Parker?

Which has more risk & volatility, KMTS or WRBY?

Do analysts rate KMTS or WRBY?

Does the media refer more to KMTS or WRBY?

Which has stronger valuation and earnings, KMTS or WRBY?

Is KMTS or WRBY more profitable?

Do insiders & institutionals have more ownership in KMTS or WRBY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools